Brown & Brown
BRO · NYSE
About BRO
- Employees
- 14,531
- Headquarters
- Daytona Beach, Florida
- Listed
- Dec 8, 1997
- Sector
- Financials
- Industry
- Insurance
- Website
- bbrown.com
BRO key statistics
- Market cap
- 23.72B
- Price-earnings ratio
- 21.84
- Dividend yield
- 0.93%
- Average volume
- 2.32M
- Volume
- 2.16M
- Open price
- $70.10
- High today
- $71.48
- Low today
- $69.39
- 52 Week high
- $90.46
- 52 Week low
- $53.81
Brown & Brown (BRO) at a glance
Brown & Brown (BRO) last traded at $70.90, with a market cap of 23.72B, a price-to-earnings ratio of 21.84 and a dividend yield of 0.93%.
Today the stock has traded between $69.39 and $71.48. The current price is 2.2% above the day's low and 0.8% below its high.
Volume so far is 2.16M shares, in line with the average of 2.32M shares a day.
Over the past year Brown & Brown has ranged from $53.81 to $90.46, and now sits 47% of the way up that range.
Brown & Brown met or beat analyst EPS estimates in 6 of the last 8 quarters. In Q2 FY26 it reported $1.07 per share against an estimate of $1.09.
The average analyst price target is $75.12, 6.0% above the current price, from 17 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy23.5%
- Hold70.6%
- Sell5.9%
- Low
- $33.22
- Now
- $70.90
- High
- $94.50
BRO earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 6 of the last 8 quarters, by 5.1% on average.
- Q3 FY24: reported $0.91 per share against an estimate of $0.8841
- Q4 FY24: reported $0.86 per share against an estimate of $0.7747
- Q1 FY25: reported $1.29 per share against an estimate of $1.32
- Q2 FY25: reported $1.03 per share against an estimate of $0.9997
- Q3 FY25: reported $1.05 per share against an estimate of $0.9478
- Q4 FY25: reported $0.93 per share against an estimate of $0.9095
- Q1 FY26: reported $1.39 per share against an estimate of $1.38
- Q2 FY26: reported $1.07 per share against an estimate of $1.09
BRO news
- Press releaseBusiness Wire
- Press releasePRNewswire
Financial Executives International Welcomes Brown & Brown as its newest Strategic Partner
- Press releaseBusiness Wire
MBA Insurance, a Division of Brown & Brown, Inc., Selects One Inc’s PremiumPay® to Modernize Inbound Payment Experience
- Press releaseBusiness Wire
Marcus & Millichap Names Brown & Brown Preferred Partner for Insurance and Risk Management
- Press releasePRNewswire
WireX Systems and Brown & Brown Launch Executive Cyber Risk Program Focused on Quantum Exposure, AI-Generated Vulnerabilities, and Machine-Speed Exploitation
- Piero Cingari
Stock Market Today: Dow Jones Roars As Industrials Rescue Wall Street From Meta-Led Tech Slide
- Press releaseGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Brown & Brown, Inc. - BRO
- Press releasePRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Brown & Brown, Inc. - BRO
Similar companies
Companies in the same industry as Brown & Brown
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.